NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 03 04:00PM ET
3.27
Dollar change
+0.04
Percentage change
1.24
%
Index- P/E- EPS (ttm)-2.23 Insider Own9.74% Shs Outstand2.55M Perf Week2.19%
Market Cap8.32M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float2.30M Perf Month2.83%
Enterprise Value5.80M PEG- EPS next Q- Inst Own4.71% Short Float2.31% Perf Quarter-28.13%
Income-4.85M P/S1.46 EPS this Y- Inst Trans-38.68% Short Ratio1.25 Perf Half Y33.84%
Sales5.68M P/B1.50 EPS next Y- ROA-54.75% Short Interest0.05M Perf YTD36.20%
Book/sh2.17 P/C2.72 EPS next 5Y- ROE-72.70% 52W High10.16 -67.81% Perf Year-7.12%
Cash/sh1.20 P/FCF- EPS past 3/5Y17.12% -6.47% ROIC-84.69% 52W Low1.93 69.25% Perf 3Y-86.33%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-9.06% 0.81% Gross Margin13.47% Volatility9.23% 7.08% Perf 5Y-94.45%
Dividend TTM- EV/Sales1.02 EPS Y/Y TTM27.73% Oper. Margin-89.80% ATR (14)0.24 Perf 10Y-51.05%
Dividend Ex-Date- Quick Ratio2.76 Sales Y/Y TTM5.05% Profit Margin-85.42% RSI (14)49.77 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio3.76 EPS Q/Q46.83% SMA200.83% Beta0.25 Target Price6.25
Payout- Debt/Eq0.10 Sales Q/Q10.03% SMA50-3.32% Rel Volume0.75 Prev Close3.23
Employees64 LT Debt/Eq0.03 EarningsJun 27 AMC SMA200-9.63% Avg Volume42.52K Price3.27
IPOMar 17, 1980 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume32,042 Change1.24%
Date Action Analyst Rating Change Price Target Change
Nov-10-20Initiated Colliers Securities Buy $13
Jan-04-18Initiated B. Riley FBR, Inc. Buy $7.50
Jul-02-25 08:08AM
Jun-26-25 08:19AM
Jun-06-25 09:30AM
Jun-05-25 08:19AM
May-22-25 08:19AM
08:19AM Loading…
May-07-25 08:19AM
Apr-23-25 08:19AM
Apr-21-25 09:02AM
Apr-17-25 08:19AM
Apr-16-25 09:00AM
Apr-15-25 08:19AM
Feb-27-25 05:18AM
Feb-26-25 08:19AM
Feb-19-25 08:19AM
Jan-17-25 10:48AM
08:19AM Loading…
Jan-16-25 08:19AM
Jan-15-25 08:19AM
Nov-21-24 08:19AM
Nov-07-24 09:09AM
Oct-30-24 08:19AM
Oct-16-24 09:00AM
Sep-04-24 08:19AM
Aug-29-24 09:00AM
Jul-16-24 07:43AM
Jul-01-24 07:47AM
May-13-24 08:19AM
Apr-29-24 11:33AM
08:19AM
Apr-15-24 07:47AM
Apr-12-24 10:52PM
07:23PM Loading…
07:23PM
Mar-28-24 08:19AM
Feb-21-24 08:19AM
Jan-23-24 08:19AM
Jan-16-24 02:51PM
08:19AM
Dec-20-23 08:30AM
Dec-18-23 07:47AM
Nov-10-23 08:19AM
Nov-08-23 08:19AM
Oct-13-23 01:10PM
06:39AM
Sep-26-23 08:19AM
Sep-22-23 03:05PM
Aug-28-23 08:19AM
Aug-25-23 05:00PM
Aug-03-23 08:19AM
Jun-21-23 08:19AM
May-18-23 08:19AM
Apr-17-23 07:47AM
Apr-14-23 04:48PM
Mar-08-23 08:19AM
Mar-07-23 04:39PM
Mar-03-23 07:30AM
Mar-02-23 05:15PM
Feb-20-23 05:57AM
Jan-23-23 06:00AM
Jan-13-23 06:39PM
Jan-10-23 08:19AM
Dec-08-22 08:19AM
Dec-01-22 05:12AM
Nov-02-22 08:19AM
Oct-14-22 10:24AM
09:46AM
09:18AM
Oct-13-22 04:50PM
Oct-11-22 06:25AM
Sep-29-22 08:19AM
Aug-31-22 06:25AM
Aug-30-22 08:19AM
Aug-29-22 04:41PM
Jul-14-22 11:50AM
08:19AM
Jun-23-22 08:19AM
May-16-22 01:20PM
May-12-22 08:19AM
Apr-26-22 08:19AM
Apr-14-22 08:37AM
Feb-08-22 12:27PM
06:39AM
Jan-13-22 08:19AM
Dec-16-21 08:19AM
Dec-03-21 04:32AM
Nov-19-21 08:19AM
Nov-04-21 06:39AM
Oct-29-21 08:19AM
Oct-19-21 06:39AM
Oct-15-21 06:39AM
Oct-12-21 06:11AM
Oct-04-21 04:30PM
Oct-01-21 02:51PM
12:47PM
11:00AM
06:39AM
06:15AM
Aug-30-21 08:19AM
Aug-13-21 01:50AM
Aug-11-21 08:19AM
Aug-05-21 08:19AM
Jul-08-21 11:20AM
Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The firm focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, North America, Asia, South America, and Middle East. The company was founded in September 1971 and is headquartered in Irvine, CA.